about phase 3

A board to discuss future MS therapies in early stage (Phase I or II) trials.

about phase 3

Postby dignan » Fri Oct 17, 2008 1:31 pm

Here's a relevant blog post:

http://pipeline.corante.com/archives/20 ... se_iii.php

It includes this quote, that I find particularly interesting:

Look, drugs fail. That happens because drug development is very difficult. Even Phase III drugs fail, probably more than they used to, thanks to stiffer endpoints and attempts to tackle trickier diseases. Lilly Research Laboratory president Steve Paul lamented at our recent PSA meeting that Phase III is "still pretty lousy," in terms of attrition rates -- around 50%. And not always for the reasons you'd expect. "You shouldn't be losing Phase III molecules for lack of efficacy," he said, but it's happening throughout the industry.
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 2:00 pm


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service